Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
Takayuki Yoshino(University of Tsukuba), Jean‐Yves Douillard(European Society for Medical Oncology), Josep Tabernero(Universitat de Vic - Universitat Central de Catalunya), George Pentheroudakis(University of Ioannina), Joong Bae Ahn(Yonsei University), Atsushi Ohtsu(National Cancer Center Hospital East), S. Zhang(Zhejiang University), Kentaro Yamazaki(Shizuoka Cancer Center), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Dirk Arnold(Asklepios Klinik Altona), Axel Grothey(Mayo Clinic in Arizona), Dawn Q. Chong(National Cancer Centre Singapore), Scott Kopetz(The University of Texas MD Anderson Cancer Center), Hiroya Taniguchi(National Cancer Center Hospital East), Kei Muro(Aichi Cancer Center), Liqun Chen(National Health Research Institutes), Hiromichi Ebi(Aichi Cancer Center), Hironobu Minami(Kobe University), Takako Eguchi-Nakajima(St. Marianna University School of Medicine), Andrés Cervantes(Universitat de València), Tae‐Woo Kim(Seoul National University), Rui‐Hua Xu(Sun Yat-sen University), M.Y. Mastura(Hospital Kuala Lumpur), Iain Tan(National Cancer Centre Singapore), Kun‐Huei Yeh(National Taiwan University), Muhammad Ismail(University Kebangsaan Malaysia Medical Centre)
Cited by 591
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k